In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Acelity announces $400mm senior notes offering

29 Feb 2016

Executive Summary

Acelity LP Inc.'s advanced wound care subsidiaries Kinetic Concepts Inc. and KCI USA Inc. offered $400mm principal amount of first lien senior secured notes due 2021 through a private transaction to qualified institutional investors. The notes mature on February 15, 2021, and accrue interest at a rate of 7.875% per year. Proceeds will help repay Acelity's existing senior term credit facility (due November 4, 2016), and will also be used for general corporate purposes.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Rehabilitation Equipment and Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By